Posts in LSE:VCT

2 hot growth stocks you may regret not buying

While many companies enjoyed stellar share price rises over 2017, separating those that will continue to climb in the next year from those that may retrace is no easy task for investors. But here are two companies that I think have a better chance than most of falling into the former category.

Rising revenues

Today's Q1 trading update from £1.3bn cap specialised technical products and services supplier Diploma (LSE:DPLM) gives some indication as to why the company became rather popular with investors over the second half of last year.

13 shares for the future

13 shares for the future

There are plenty of shares screaming 'buy', according to companies analyst Richard Beddard, and one that looks "very, very cheap".

Broker Forecast - JP Morgan Cazenove issues a broker note on Victrex PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Victrex PLC (LON:VCT) and raised its price target to 2580p (from 2250p).

Victrex schedules AGM, nominates non-execs

Victrex confirmed that it intends to hold its Annual General Meeting on 9 February.

As part of the business of the Meeting, the Board will be recommending two new non-executive directors, Ms Janet Ashdown and Mr Brendan Connolly.

Mr David Hummel, an executive director and Mr Patrick De Smedt, non-executive director and Chairman of the Remuneration Committee will step down from the Board at the AGM.

At 1:01pm: (LON:VCT) Victrex PLC share price was +11p at 2661p

2 growth stocks I’d buy and hold for 2018

Shares in FTSE 250 pharmaceutical group Indivior (LSE:INDV) have risen by 177% since the firm was spun out of consumer goods firm Reckitt Benckiser at the end of 2014.

However, it hasn't been a smooth ride for investors in this opioid addiction treatment specialist. The shifting tides of the firm's legal battles against generic competitors have caused whiplash movements in the share price. A strong nerve has been required to continue holding.

Director Deals - Victrex PLC (VCT)

Dr Martin Court, Executive Director, sold 441 shares in the company on the 15th December 2017 at a price of 2618.00p. The Director now holds 1,396 shares representing 0.00% of the shares in issue.

NOTE: Sold to meet tax liabilities etc.
Total holding includes 35 shares - dividend.

Director deals data provided by www.directorsholdings.com

Director Deals - Victrex PLC (VCT)

Dr Martin Court, Executive Director, has transferred in 934 shares in the company on the 15th December 2017 at a price of 0.00p. The Director now holds 1,802 shares representing 0.00% of the shares in issue.

NOTE: Vesting

Director deals data provided by www.directorsholdings.com

Director Deals - Victrex PLC (VCT)

Tim Cooper, Executive Director, sold 477 shares in the company on the 15th December 2017 at a price of 2618.00p. The Director now holds 66,105 shares.

NOTE: Sold to meet tax liabilities etc.

Director deals data provided by www.directorsholdings.com

Director Deals - Victrex PLC (VCT)

Tim Cooper, Executive Director, has transferred in 1,011 shares in the company on the 15th December 2017 at a price of 0.00p. The Director now holds 66,582 shares.

NOTE: Vesting

Director deals data provided by www.directorsholdings.com

15 stocks in the 'buy zone'

15 stocks in the 'buy zone'

After rejigging the algorithm and reassessing every share ranked by his Decision Engine stock screener, companies analyst Richard Beddard has a lot to report on.